These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32952666)

  • 1. Biointerface engineering nanoplatforms for cancer-targeted drug delivery.
    Zhang H; Dong S; Li Z; Feng X; Xu W; Tulinao CMS; Jiang Y; Ding J
    Asian J Pharm Sci; 2020 Jul; 15(4):397-415. PubMed ID: 32952666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy.
    Chen BQ; Zhao Y; Zhang Y; Pan YJ; Xia HY; Kankala RK; Wang SB; Liu G; Chen AZ
    Bioact Mater; 2023 Mar; 21():1-19. PubMed ID: 36017071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
    Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
    Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic hybrid membrane-based nanoplatforms: synthesis, properties and biomedical applications.
    Liao Y; Zhang Y; Blum NT; Lin J; Huang P
    Nanoscale Horiz; 2020 Sep; 5(9):1293-1302. PubMed ID: 32608425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
    Sun X; Zhang G; Wu Z
    Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy.
    Xu CH; Ye PJ; Zhou YC; He DX; Wei H; Yu CY
    Acta Biomater; 2020 Mar; 105():1-14. PubMed ID: 32001369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
    Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
    J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell membrane-camouflaged nanoparticles for drug delivery.
    Luk BT; Zhang L
    J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoplatforms: The future of oral cancer treatment.
    Senevirathna K; Jayawickrama SM; Jayasinghe YA; Prabani KIP; Akshala K; Pradeep RGGR; Damayanthi HDWT; Hettiarachchi K; Dorji T; Lucero-Prisno DE; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
    Health Sci Rep; 2023 Aug; 6(8):e1471. PubMed ID: 37547360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.
    Yu B; Xue X; Yin Z; Cao L; Li M; Huang J
    Front Cell Dev Biol; 2022; 10():844050. PubMed ID: 35295856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic.
    Li S; Liu J; Sun M; Wang J; Wang C; Sun Y
    Front Pharmacol; 2020; 11():24. PubMed ID: 32116701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.
    Moon H; Lee J; Min J; Kang S
    Biomacromolecules; 2014 Oct; 15(10):3794-801. PubMed ID: 25180761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research update on cell membrane camouflaged nanoparticles for cancer therapy.
    Wang C; Wu S
    Front Bioeng Biotechnol; 2022; 10():944518. PubMed ID: 35992357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics.
    Vijayan V; Uthaman S; Park IK
    Polymers (Basel); 2018 Sep; 10(9):. PubMed ID: 30960908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.
    Fathi M; Majidi S; Zangabad PS; Barar J; Erfan-Niya H; Omidi Y
    Med Res Rev; 2018 Sep; 38(6):2110-2136. PubMed ID: 29846948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition Sites for Cancer-targeting Drug Delivery Systems.
    Guan S; Zhang Q; Bao J; Hu R; Czech T; Tang J
    Curr Drug Metab; 2019; 20(10):815-834. PubMed ID: 31580248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanogel: A Versatile Nano-Delivery System for Biomedical Applications.
    Yin Y; Hu B; Yuan X; Cai L; Gao H; Yang Q
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.